Mirae Asset Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 0.35 %Nav, as on 28-03-2025

  • Previous Nav

  • Net Change on 28-03-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Mirae Asset Healthcare Fund -Regular Growth 9.05 -6.36 17.24 17.98 28.96 21.18
BSE Health Care - TRI 5.27 -6.32 20.51 20.14 29.73 15.53
BSE SENSEX - TRI 3.60 -1.37 7.95 11.84 22.30 13.40

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 17.24 17.98 28.96 1.96 2,441.13
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 12.22 18.67 28.38 1.82 7,637.04
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 19.87 22.77 31.54 1.94 4,611.47
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 19.98 23.23 30.44 1.95 3,312.89
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 14.12 20.01 29.40 1.93 2,950.74
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 14.26 18.94 27.67 2.19 1,103.99

Fund Holdings as on 28-February-2025

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Aurobindo Pharma Limited

  • Divi's Laboratories Limited

  • Lupin Limited

  • Apollo Hospitals Enterprise Limited

  • Glenmark Pharmaceuticals Limited

  • Suven Pharmaceuticals Limited

  • Dr. Reddy's Laboratories Limited

  • Krishna Institute Of Medical Sciences Limited

  • Gland Pharma Limited

  • Torrent Pharmaceuticals Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Syngene International Limited

  • Mankind Pharma Limited

  • Alkem Laboratories Limited

  • Sai Life Sciences Limited

  • Wockhardt Limited

  • Fortis Healthcare Limited

  • IPCA Laboratories Limited

  • Aster DM Healthcare Limited

  • Onesource Specialty Pharma Limited

  • Biocon Limited

  • Zydus Lifesciences Limited

  • Sagility India Limited

  • Alembic Pharmaceuticals Limited

  • Neogen Chemicals Limited

  • Laxmi Dental Limited

  • SRF Limited

  • TREPS

  • Deepak Nitrite Limited

  • Suraksha Diagnostic Limited

  • Net Receivables / (Payables)

  • Mirae Asset Liquid Fund - Direct Growth

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Chemicals

  • Medical Equipment/Supplies/Accessories

  • Miscellaneous

View More

Fund Manager

  • Education:B.Com & C.A.
  • Experience:12
  • Basic Details:Mr. Tanmay Mehta has over 12 years of experience primarily into equity research. He has been associated with the AMC since Jan 2021. Prior to this, Mr. Mehta has worked across Institutional Equity Research and Investment Banking Functions at SBI Capital Markets. He is a Chartered Accountant and has also cleared CFA (US).
  • Funds Managed:
  • Mirae Asset Healthcare Fund
  • Mirae Asset Healthcare Fund

  • Cash

  • Equity

  • MFU

View More

About Mirae Asset Healthcare Fund

Scheme Analysis

Mirae Asset Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Mirae Asset Mutual Fund. It was launched on 02-Jul-2018 and currently has an AUM of ₹2,441.13 crore. Mirae Asset Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of Mirae Asset Healthcare Fund ended up ₹0.13(0.35%)yesterday to ₹36.514.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Mirae Asset Healthcare Fund is managed by Vrijesh Kasera and Tanmay Mehta.

Fund House Contact

Unit 606, 6th Floor, Windsor Building, Off CST Road, Kalina, Santacruz (E), Mumbai - 400 098

022-67800300
022-67253940